F. Demmel

Papers

Total Citations

H-Index

About

F. Demmel is a pioneering researcher at the intersection of biomedical engineering and personalized oncology, specializing in sensor-based platforms for real-time monitoring of living cells and tissues. Their major contributions center on developing automated, non-invasive systems that integrate microsensors with cell culture environments, enabling continuous, controlled assays of cellular responses to therapeutic agents. This work has profound implications for personalized cancer chemotherapy, allowing clinicians to test drug efficacy on patient-derived tissues before treatment. Demmel's most cited paper, "Automated platform for sensor-based monitoring and controlled assays of living cells and tissues" (2013, 26 citations), established a foundational methodology for high-throughput, dynamic cell analysis. A closely related study, "Sensor-based cell and tissue screening for personalized cancer chemotherapy" (2012, 24 citations), directly translated this technology into a clinical screening tool, demonstrating its potential to tailor chemotherapy regimens to individual patients. Though their citation counts are modest, Demmel's work is notable for its translational impact, bridging lab-on-a-chip innovation with practical, patient-specific cancer care. Their research continues to inspire advances in precision medicine and bio-sensing technologies.